Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Webinars

Personalized Medicine: Business Solutions for Regulatory & Reimbursement Uncertainties

Topic:

Cardiovascular disease, life threatening cancer, anti-psychotics, rare diseases, an aged population. Drugs developed in these areas using personalized medicine are focused on providing earlier diagnosis, more effective prevention and successful treatment of these diseases.

Governments throughout the world are facing escalating demands on their limited resources as they struggle to provide healthcare services while also dealing with the requirements to modernize their delivery systems. These realities necessitate the need to examine the long term costs and benefits of various healthcare technologies, diagnostics, and therapeutic options, including personalized medicine.

Session speaker and presentation:

Patrick Terry, Principal, Pricing & Reimbursement/Market Access Practice at Scientia Advisors.

During this webinar sponsored by Elsevier Business Intelligence, Patrick Terry will discuss the important aspects of business activities in personalized medicine. He will focus on: pricing and market access, coding, coverage and reimbursement, partnering for development and more. He will examine the challenges and propose solutions to consider for your activities in personalized medicine.

Attendees will:

• Discuss companion diagnostic development and what impact biomarkers will have to commercial diagnostics
• Discover the rationale for reimbursement: Understanding coverage and beyond
• Learn how to get FDA clearance and navigating the often confusing claims language
• Hear how to maximize clinical study results while addressing costs
• Understand why evidence development and communication with the FDA makes a big difference

More Information »